Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroencephalography | 155 | 2024 | 6309 | 7.370 |
Why?
|
Seizures | 54 | 2024 | 2996 | 4.870 |
Why?
|
Epilepsy | 70 | 2024 | 3324 | 4.670 |
Why?
|
Cerebral Cortex | 52 | 2024 | 5827 | 3.520 |
Why?
|
Epilepsies, Partial | 15 | 2024 | 435 | 3.400 |
Why?
|
Brain Waves | 19 | 2024 | 418 | 3.370 |
Why?
|
Electrodes, Implanted | 34 | 2024 | 841 | 2.460 |
Why?
|
Neurons | 38 | 2024 | 9504 | 2.160 |
Why?
|
Action Potentials | 23 | 2024 | 1837 | 1.980 |
Why?
|
Signal Processing, Computer-Assisted | 22 | 2020 | 1496 | 1.980 |
Why?
|
Brain | 71 | 2024 | 27439 | 1.960 |
Why?
|
Sleep | 31 | 2024 | 4796 | 1.910 |
Why?
|
Status Epilepticus | 9 | 2023 | 464 | 1.790 |
Why?
|
Brain Mapping | 33 | 2024 | 6740 | 1.780 |
Why?
|
Neocortex | 10 | 2024 | 417 | 1.760 |
Why?
|
Sleep Stages | 18 | 2023 | 702 | 1.670 |
Why?
|
Models, Neurological | 25 | 2021 | 1784 | 1.640 |
Why?
|
Microelectrodes | 14 | 2024 | 308 | 1.490 |
Why?
|
Quadriplegia | 14 | 2023 | 226 | 1.490 |
Why?
|
Motor Cortex | 12 | 2022 | 1015 | 1.450 |
Why?
|
Deep Brain Stimulation | 11 | 2024 | 847 | 1.430 |
Why?
|
Epilepsy, Temporal Lobe | 8 | 2023 | 390 | 1.320 |
Why?
|
Implantable Neurostimulators | 6 | 2021 | 75 | 1.270 |
Why?
|
Thalamus | 11 | 2024 | 1051 | 1.230 |
Why?
|
Temporal Lobe | 10 | 2024 | 1728 | 1.230 |
Why?
|
Nerve Net | 19 | 2024 | 2362 | 1.220 |
Why?
|
Theta Rhythm | 6 | 2024 | 221 | 1.180 |
Why?
|
Propofol | 7 | 2023 | 607 | 1.160 |
Why?
|
Nonlinear Dynamics | 11 | 2023 | 496 | 1.110 |
Why?
|
Electric Stimulation Therapy | 6 | 2021 | 636 | 0.980 |
Why?
|
Speech Perception | 6 | 2024 | 512 | 0.970 |
Why?
|
Epilepsy, Generalized | 4 | 2024 | 181 | 0.940 |
Why?
|
Scalp | 7 | 2022 | 392 | 0.900 |
Why?
|
Electrodes | 15 | 2024 | 618 | 0.900 |
Why?
|
Gyrus Cinguli | 4 | 2019 | 1136 | 0.890 |
Why?
|
Prefrontal Cortex | 9 | 2024 | 2251 | 0.860 |
Why?
|
Endocrine Glands | 1 | 2023 | 101 | 0.850 |
Why?
|
Learning | 3 | 2022 | 1762 | 0.840 |
Why?
|
Speech | 4 | 2024 | 558 | 0.840 |
Why?
|
High-Frequency Ventilation | 1 | 2023 | 90 | 0.830 |
Why?
|
Consciousness | 4 | 2023 | 603 | 0.790 |
Why?
|
Body Fluids | 1 | 2023 | 322 | 0.760 |
Why?
|
Freedom | 1 | 2021 | 69 | 0.750 |
Why?
|
Malformations of Cortical Development | 1 | 2023 | 176 | 0.740 |
Why?
|
Nerve Tissue | 1 | 2021 | 78 | 0.730 |
Why?
|
Neural Pathways | 12 | 2023 | 3122 | 0.700 |
Why?
|
Evoked Potentials | 11 | 2024 | 1057 | 0.680 |
Why?
|
Humans | 251 | 2024 | 768369 | 0.680 |
Why?
|
Sleep, REM | 5 | 2024 | 595 | 0.670 |
Why?
|
Electric Stimulation | 11 | 2024 | 1743 | 0.650 |
Why?
|
Alpha Rhythm | 1 | 2019 | 111 | 0.650 |
Why?
|
Semantics | 6 | 2024 | 617 | 0.640 |
Why?
|
Pyramidal Cells | 5 | 2021 | 367 | 0.640 |
Why?
|
Anticonvulsants | 7 | 2022 | 1923 | 0.620 |
Why?
|
Young Adult | 63 | 2024 | 60038 | 0.610 |
Why?
|
Algorithms | 29 | 2020 | 14157 | 0.610 |
Why?
|
Electrophysiological Phenomena | 5 | 2021 | 309 | 0.600 |
Why?
|
Adult | 117 | 2024 | 223528 | 0.600 |
Why?
|
Stereotaxic Techniques | 5 | 2024 | 556 | 0.590 |
Why?
|
Hippocampus | 13 | 2024 | 3783 | 0.590 |
Why?
|
Magnetoencephalography | 12 | 2018 | 641 | 0.560 |
Why?
|
Beta Rhythm | 1 | 2017 | 65 | 0.540 |
Why?
|
Nucleus Accumbens | 1 | 2019 | 372 | 0.530 |
Why?
|
Male | 130 | 2024 | 364761 | 0.510 |
Why?
|
Frontal Lobe | 6 | 2021 | 1427 | 0.510 |
Why?
|
Transcranial Magnetic Stimulation | 3 | 2023 | 1489 | 0.490 |
Why?
|
Rest | 1 | 2020 | 952 | 0.480 |
Why?
|
Models, Theoretical | 5 | 2019 | 3590 | 0.470 |
Why?
|
Software | 7 | 2020 | 4465 | 0.470 |
Why?
|
Acoustic Stimulation | 5 | 2024 | 1253 | 0.440 |
Why?
|
Middle Aged | 91 | 2024 | 223406 | 0.440 |
Why?
|
Female | 118 | 2024 | 396926 | 0.430 |
Why?
|
Epilepsy, Complex Partial | 2 | 2017 | 56 | 0.420 |
Why?
|
Unconsciousness | 4 | 2023 | 251 | 0.420 |
Why?
|
Neurology | 2 | 2024 | 786 | 0.410 |
Why?
|
Amygdala | 3 | 2019 | 1382 | 0.410 |
Why?
|
Coma | 4 | 2018 | 488 | 0.400 |
Why?
|
Wakefulness | 7 | 2022 | 1280 | 0.400 |
Why?
|
Silicon | 2 | 2023 | 143 | 0.400 |
Why?
|
Skull | 3 | 2015 | 832 | 0.390 |
Why?
|
Limbic Encephalitis | 1 | 2011 | 36 | 0.380 |
Why?
|
Wireless Technology | 3 | 2021 | 99 | 0.380 |
Why?
|
Dendrites | 6 | 2021 | 471 | 0.370 |
Why?
|
Phonetics | 3 | 2024 | 204 | 0.350 |
Why?
|
Neuromuscular Junction | 6 | 1997 | 406 | 0.340 |
Why?
|
Memory Disorders | 3 | 2020 | 1204 | 0.330 |
Why?
|
Visual Perception | 3 | 2015 | 1406 | 0.330 |
Why?
|
Movement | 6 | 2024 | 1489 | 0.320 |
Why?
|
Computer Simulation | 17 | 2020 | 6278 | 0.310 |
Why?
|
Neurotoxicity Syndromes | 2 | 2022 | 303 | 0.310 |
Why?
|
Neurophysiology | 3 | 2023 | 145 | 0.310 |
Why?
|
Language | 5 | 2024 | 1557 | 0.300 |
Why?
|
Heart Arrest | 4 | 2020 | 1516 | 0.290 |
Why?
|
Delta Rhythm | 2 | 2018 | 82 | 0.290 |
Why?
|
Alzheimer Disease | 4 | 2024 | 8723 | 0.290 |
Why?
|
Psychomotor Performance | 5 | 2019 | 1894 | 0.290 |
Why?
|
Foramen Ovale | 2 | 2024 | 17 | 0.280 |
Why?
|
Ion Channels | 3 | 2018 | 1044 | 0.280 |
Why?
|
Extracellular Space | 3 | 2021 | 565 | 0.270 |
Why?
|
Biophysics | 2 | 2021 | 379 | 0.270 |
Why?
|
Hypoxia-Ischemia, Brain | 3 | 2019 | 359 | 0.270 |
Why?
|
Ion Channel Gating | 1 | 2008 | 429 | 0.270 |
Why?
|
Cognition | 11 | 2024 | 7062 | 0.270 |
Why?
|
Macaca mulatta | 4 | 2021 | 2362 | 0.260 |
Why?
|
Primates | 2 | 2019 | 523 | 0.260 |
Why?
|
Circadian Rhythm | 4 | 2023 | 2585 | 0.260 |
Why?
|
Polypharmacy | 1 | 2008 | 307 | 0.260 |
Why?
|
Bayes Theorem | 3 | 2019 | 2359 | 0.250 |
Why?
|
Decision Making | 4 | 2019 | 3961 | 0.250 |
Why?
|
Animals | 36 | 2024 | 169424 | 0.250 |
Why?
|
Rats | 12 | 2024 | 23839 | 0.240 |
Why?
|
Magnetic Resonance Imaging | 18 | 2023 | 36840 | 0.240 |
Why?
|
Spinal Cord Injuries | 2 | 2023 | 928 | 0.240 |
Why?
|
Cortical Synchronization | 3 | 2014 | 78 | 0.230 |
Why?
|
Adolescent | 32 | 2024 | 89163 | 0.230 |
Why?
|
Intensive Care Units | 6 | 2023 | 3804 | 0.230 |
Why?
|
Neuronal Plasticity | 2 | 2024 | 1448 | 0.230 |
Why?
|
Monitoring, Physiologic | 4 | 2018 | 1795 | 0.230 |
Why?
|
Wavelet Analysis | 2 | 2021 | 56 | 0.220 |
Why?
|
Uncertainty | 1 | 2008 | 758 | 0.220 |
Why?
|
Sleep Apnea Syndromes | 3 | 2022 | 981 | 0.220 |
Why?
|
Electrooculography | 2 | 2013 | 113 | 0.210 |
Why?
|
Primary Dysautonomias | 1 | 2022 | 28 | 0.210 |
Why?
|
Autoantibodies | 1 | 2011 | 2131 | 0.210 |
Why?
|
Diagnostic Tests, Routine | 1 | 2008 | 792 | 0.210 |
Why?
|
Species Specificity | 4 | 2021 | 2419 | 0.210 |
Why?
|
Electromagnetic Fields | 2 | 2023 | 290 | 0.200 |
Why?
|
Photic Stimulation | 5 | 2019 | 2005 | 0.200 |
Why?
|
Visual Cortex | 2 | 2020 | 1112 | 0.200 |
Why?
|
Time Factors | 21 | 2020 | 40271 | 0.200 |
Why?
|
Computer Systems | 1 | 2023 | 470 | 0.200 |
Why?
|
Area Under Curve | 3 | 2020 | 1640 | 0.200 |
Why?
|
Sensitivity and Specificity | 11 | 2020 | 14725 | 0.190 |
Why?
|
Anesthetics | 2 | 2020 | 525 | 0.190 |
Why?
|
Aged | 35 | 2024 | 171514 | 0.190 |
Why?
|
Automation | 3 | 2017 | 588 | 0.190 |
Why?
|
Epilepsia Partialis Continua | 1 | 2021 | 25 | 0.190 |
Why?
|
Numerical Analysis, Computer-Assisted | 2 | 2012 | 118 | 0.190 |
Why?
|
Anterior Temporal Lobectomy | 2 | 2022 | 46 | 0.180 |
Why?
|
Subarachnoid Hemorrhage | 3 | 2018 | 1041 | 0.180 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 363 | 0.180 |
Why?
|
Calibration | 7 | 2018 | 823 | 0.180 |
Why?
|
Kainic Acid | 1 | 2020 | 203 | 0.170 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2020 | 142 | 0.170 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2018 | 247 | 0.170 |
Why?
|
Prostheses and Implants | 3 | 2021 | 1279 | 0.170 |
Why?
|
Anesthetics, Intravenous | 2 | 2014 | 396 | 0.170 |
Why?
|
Neural Prostheses | 1 | 2020 | 23 | 0.170 |
Why?
|
Volition | 1 | 2020 | 61 | 0.170 |
Why?
|
Spectrum Analysis | 3 | 2014 | 450 | 0.170 |
Why?
|
Electric Conductivity | 5 | 2021 | 408 | 0.170 |
Why?
|
Self-Help Devices | 2 | 2021 | 62 | 0.170 |
Why?
|
Dominance, Cerebral | 2 | 2018 | 624 | 0.170 |
Why?
|
Anterior Thalamic Nuclei | 1 | 2019 | 27 | 0.170 |
Why?
|
Cell Size | 1 | 2021 | 626 | 0.170 |
Why?
|
ROC Curve | 4 | 2020 | 3623 | 0.160 |
Why?
|
Autoimmune Diseases | 1 | 2011 | 2260 | 0.160 |
Why?
|
Reaction Time | 5 | 2022 | 2102 | 0.160 |
Why?
|
Mental Recall | 2 | 2022 | 1226 | 0.160 |
Why?
|
Reading | 3 | 2012 | 543 | 0.160 |
Why?
|
Interneurons | 1 | 2023 | 592 | 0.160 |
Why?
|
Craniotomy | 1 | 2023 | 748 | 0.160 |
Why?
|
Hypothermia, Induced | 2 | 2015 | 756 | 0.160 |
Why?
|
Nanotubes | 1 | 2019 | 83 | 0.160 |
Why?
|
Comprehension | 1 | 2024 | 641 | 0.160 |
Why?
|
Mental Processes | 2 | 2010 | 247 | 0.160 |
Why?
|
Electrophysiology | 4 | 2010 | 1266 | 0.150 |
Why?
|
Synapses | 4 | 2016 | 1766 | 0.150 |
Why?
|
Memory | 4 | 2020 | 2210 | 0.150 |
Why?
|
Treatment Outcome | 16 | 2024 | 65408 | 0.150 |
Why?
|
Drug Resistance | 3 | 2014 | 1599 | 0.150 |
Why?
|
Internal Capsule | 1 | 2019 | 138 | 0.150 |
Why?
|
Caudate Nucleus | 1 | 2019 | 391 | 0.150 |
Why?
|
Platinum | 1 | 2019 | 222 | 0.150 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.150 |
Why?
|
Biostatistics | 1 | 2019 | 165 | 0.150 |
Why?
|
Anesthesia, General | 2 | 2023 | 1185 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 4 | 2016 | 20763 | 0.150 |
Why?
|
Anesthesia Recovery Period | 1 | 2018 | 155 | 0.150 |
Why?
|
Reproducibility of Results | 11 | 2023 | 20232 | 0.140 |
Why?
|
Retrospective Studies | 22 | 2024 | 81835 | 0.140 |
Why?
|
Somatosensory Cortex | 1 | 2021 | 516 | 0.140 |
Why?
|
Predictive Value of Tests | 8 | 2019 | 15459 | 0.140 |
Why?
|
Hepatic Encephalopathy | 1 | 2018 | 144 | 0.140 |
Why?
|
Operating Rooms | 1 | 2023 | 799 | 0.140 |
Why?
|
Ketamine | 1 | 2023 | 524 | 0.140 |
Why?
|
Auditory Cortex | 1 | 2021 | 365 | 0.140 |
Why?
|
Proteins | 1 | 2011 | 6009 | 0.140 |
Why?
|
Muscles | 4 | 1996 | 1582 | 0.140 |
Why?
|
Artifacts | 3 | 2019 | 1927 | 0.130 |
Why?
|
Imaging, Three-Dimensional | 3 | 2016 | 4077 | 0.130 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18390 | 0.130 |
Why?
|
Mammals | 1 | 2021 | 1136 | 0.130 |
Why?
|
Decision Support Techniques | 3 | 2018 | 2010 | 0.130 |
Why?
|
Emotions | 2 | 2019 | 2772 | 0.130 |
Why?
|
Synaptic Transmission | 3 | 2020 | 1173 | 0.130 |
Why?
|
Linear Models | 4 | 2020 | 5880 | 0.130 |
Why?
|
Cervical Vertebrae | 1 | 2022 | 982 | 0.130 |
Why?
|
Analysis of Variance | 3 | 2013 | 6242 | 0.130 |
Why?
|
Nanotechnology | 1 | 2021 | 714 | 0.130 |
Why?
|
Electromyography | 1 | 2020 | 1399 | 0.120 |
Why?
|
Magnetics | 1 | 2018 | 599 | 0.120 |
Why?
|
Models, Psychological | 1 | 2019 | 835 | 0.120 |
Why?
|
Calcium | 3 | 1999 | 5793 | 0.120 |
Why?
|
Early Diagnosis | 3 | 2019 | 1196 | 0.120 |
Why?
|
International Classification of Diseases | 1 | 2020 | 925 | 0.120 |
Why?
|
Health Personnel | 2 | 2020 | 3384 | 0.120 |
Why?
|
Communication | 3 | 2020 | 3910 | 0.110 |
Why?
|
Hand Strength | 2 | 2020 | 465 | 0.110 |
Why?
|
Time | 2 | 2022 | 546 | 0.110 |
Why?
|
Stereotyping | 1 | 2016 | 243 | 0.110 |
Why?
|
Brain Ischemia | 2 | 2018 | 3038 | 0.110 |
Why?
|
Electroencephalography Phase Synchronization | 1 | 2013 | 8 | 0.110 |
Why?
|
Collodion | 1 | 2013 | 34 | 0.110 |
Why?
|
Iontophoresis | 3 | 1999 | 75 | 0.110 |
Why?
|
Documentation | 1 | 2020 | 913 | 0.110 |
Why?
|
Halorhodopsins | 1 | 2013 | 9 | 0.110 |
Why?
|
Biomedical Engineering | 2 | 2020 | 286 | 0.110 |
Why?
|
Polysomnography | 4 | 2023 | 1864 | 0.110 |
Why?
|
Consciousness Disorders | 1 | 2018 | 445 | 0.110 |
Why?
|
Cerebral Infarction | 1 | 2018 | 983 | 0.110 |
Why?
|
Optical Fibers | 1 | 2013 | 135 | 0.100 |
Why?
|
Neural Inhibition | 1 | 2017 | 588 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2531 | 0.100 |
Why?
|
Arm | 2 | 2014 | 590 | 0.100 |
Why?
|
Diffusion Tensor Imaging | 2 | 2021 | 2427 | 0.100 |
Why?
|
Bhutan | 3 | 2017 | 61 | 0.100 |
Why?
|
Man-Machine Systems | 1 | 2012 | 42 | 0.100 |
Why?
|
Pilot Projects | 3 | 2022 | 8730 | 0.100 |
Why?
|
Quality of Life | 7 | 2020 | 13497 | 0.100 |
Why?
|
Age Factors | 4 | 2020 | 18477 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 7 | 2024 | 8201 | 0.100 |
Why?
|
Attention | 1 | 2022 | 2423 | 0.100 |
Why?
|
Vibration | 1 | 2014 | 335 | 0.100 |
Why?
|
Models, Anatomic | 1 | 2015 | 684 | 0.100 |
Why?
|
Data Interpretation, Statistical | 6 | 2013 | 2705 | 0.100 |
Why?
|
Cytoplasm | 1 | 1996 | 1503 | 0.090 |
Why?
|
Touch | 1 | 2014 | 316 | 0.090 |
Why?
|
Fiber Optic Technology | 1 | 2013 | 291 | 0.090 |
Why?
|
Cerebrospinal Fluid | 2 | 2011 | 545 | 0.090 |
Why?
|
Epilepsy, Tonic-Clonic | 2 | 2024 | 54 | 0.090 |
Why?
|
Child | 11 | 2024 | 80856 | 0.090 |
Why?
|
User-Computer Interface | 2 | 2014 | 1398 | 0.090 |
Why?
|
Critical Care | 2 | 2014 | 2717 | 0.090 |
Why?
|
Motor Neurons | 3 | 1993 | 872 | 0.090 |
Why?
|
Movement Disorders | 1 | 2015 | 464 | 0.090 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1703 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1905 | 0.090 |
Why?
|
Imagination | 3 | 2020 | 226 | 0.090 |
Why?
|
Equipment Design | 3 | 2021 | 3530 | 0.090 |
Why?
|
Longitudinal Studies | 4 | 2020 | 14766 | 0.090 |
Why?
|
Transduction, Genetic | 1 | 2013 | 903 | 0.090 |
Why?
|
Neurosurgical Procedures | 3 | 2016 | 2096 | 0.090 |
Why?
|
Pilocarpine | 1 | 2009 | 64 | 0.090 |
Why?
|
Occipital Lobe | 1 | 2012 | 376 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2018 | 1472 | 0.080 |
Why?
|
Quality Improvement | 2 | 2022 | 3858 | 0.080 |
Why?
|
Evoked Potentials, Motor | 1 | 2013 | 465 | 0.080 |
Why?
|
Likelihood Functions | 2 | 2014 | 993 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2238 | 0.080 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2019 | 1509 | 0.080 |
Why?
|
Models, Biological | 2 | 2018 | 9505 | 0.080 |
Why?
|
Patients | 1 | 2016 | 909 | 0.080 |
Why?
|
Social Stigma | 1 | 2016 | 785 | 0.080 |
Why?
|
Piracetam | 1 | 2009 | 88 | 0.080 |
Why?
|
Task Performance and Analysis | 1 | 2013 | 771 | 0.080 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2022 | 1890 | 0.080 |
Why?
|
Linguistics | 1 | 2009 | 110 | 0.080 |
Why?
|
Dementia | 1 | 2024 | 2724 | 0.080 |
Why?
|
Decision Theory | 1 | 2008 | 27 | 0.080 |
Why?
|
Robotics | 2 | 2014 | 826 | 0.080 |
Why?
|
Neurologic Examination | 1 | 2012 | 916 | 0.080 |
Why?
|
Syncope | 1 | 2011 | 430 | 0.080 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2009 | 239 | 0.080 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 695 | 0.080 |
Why?
|
Feedback, Physiological | 3 | 2019 | 480 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 2015 | 952 | 0.080 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2013 | 752 | 0.070 |
Why?
|
Feasibility Studies | 4 | 2023 | 5308 | 0.070 |
Why?
|
Postoperative Complications | 3 | 2016 | 15879 | 0.070 |
Why?
|
Databases, Factual | 2 | 2020 | 8081 | 0.070 |
Why?
|
Physical Examination | 1 | 2013 | 1262 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5532 | 0.070 |
Why?
|
Excitatory Postsynaptic Potentials | 2 | 1999 | 369 | 0.070 |
Why?
|
Prognosis | 8 | 2020 | 30031 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 2023 | 905 | 0.070 |
Why?
|
Critical Illness | 2 | 2022 | 2754 | 0.070 |
Why?
|
Nomograms | 1 | 2008 | 236 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1677 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2022 | 4877 | 0.070 |
Why?
|
Reference Values | 1 | 2013 | 4941 | 0.070 |
Why?
|
Photolysis | 2 | 1996 | 94 | 0.070 |
Why?
|
Acetylcholine | 3 | 2016 | 629 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2012 | 998 | 0.060 |
Why?
|
Follow-Up Studies | 9 | 2020 | 39429 | 0.060 |
Why?
|
Xenopus | 3 | 1997 | 710 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26348 | 0.060 |
Why?
|
Pattern Recognition, Visual | 1 | 2012 | 825 | 0.060 |
Why?
|
Aging | 3 | 2020 | 8762 | 0.060 |
Why?
|
Haplorhini | 2 | 2016 | 524 | 0.060 |
Why?
|
Lung Abscess | 1 | 2005 | 40 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59679 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22365 | 0.060 |
Why?
|
Foot Deformities, Acquired | 1 | 2005 | 27 | 0.060 |
Why?
|
Epidermolysis Bullosa | 1 | 2005 | 29 | 0.060 |
Why?
|
Hand Deformities, Acquired | 1 | 2005 | 36 | 0.060 |
Why?
|
Intralaminar Thalamic Nuclei | 1 | 2024 | 14 | 0.060 |
Why?
|
Mice | 6 | 2021 | 82051 | 0.060 |
Why?
|
Amyloid beta-Peptides | 1 | 2018 | 3892 | 0.060 |
Why?
|
Prospective Studies | 9 | 2023 | 54913 | 0.060 |
Why?
|
Epidermolysis Bullosa Simplex | 1 | 2004 | 12 | 0.060 |
Why?
|
Brain Abscess | 1 | 2005 | 123 | 0.060 |
Why?
|
Pneumonia, Aspiration | 1 | 2005 | 145 | 0.060 |
Why?
|
Motor Activity | 1 | 2014 | 2722 | 0.060 |
Why?
|
Electrocardiography | 3 | 2012 | 6410 | 0.060 |
Why?
|
Paresis | 1 | 2005 | 177 | 0.060 |
Why?
|
Evoked Potentials, Visual | 2 | 2018 | 420 | 0.060 |
Why?
|
Potassium | 2 | 2017 | 1319 | 0.050 |
Why?
|
Peroxides | 1 | 2023 | 76 | 0.050 |
Why?
|
Tetracycline | 1 | 2004 | 216 | 0.050 |
Why?
|
Telemedicine | 1 | 2021 | 3104 | 0.050 |
Why?
|
Periodicity | 2 | 2017 | 348 | 0.050 |
Why?
|
N-Methylaspartate | 1 | 2023 | 231 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2011 | 1600 | 0.050 |
Why?
|
Disease Management | 1 | 2013 | 2533 | 0.050 |
Why?
|
Narration | 1 | 2024 | 221 | 0.050 |
Why?
|
Behavior, Animal | 1 | 2009 | 1882 | 0.050 |
Why?
|
Image Enhancement | 1 | 2012 | 2895 | 0.050 |
Why?
|
Normal Distribution | 1 | 2022 | 272 | 0.050 |
Why?
|
Models, Statistical | 4 | 2021 | 5103 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2882 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4049 | 0.050 |
Why?
|
Cues | 2 | 2021 | 884 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2019 | 4816 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2023 | 501 | 0.050 |
Why?
|
Fourier Analysis | 2 | 2013 | 441 | 0.050 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2021 | 142 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 1996 | 1100 | 0.050 |
Why?
|
Noise | 1 | 2023 | 292 | 0.050 |
Why?
|
Random Allocation | 2 | 2018 | 2399 | 0.050 |
Why?
|
Death, Sudden | 1 | 2022 | 301 | 0.050 |
Why?
|
Problem Solving | 1 | 2023 | 443 | 0.040 |
Why?
|
Observer Variation | 2 | 2020 | 2622 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6995 | 0.040 |
Why?
|
Risk | 1 | 2012 | 9642 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7605 | 0.040 |
Why?
|
Research Subjects | 1 | 2022 | 249 | 0.040 |
Why?
|
Neuropsychological Tests | 3 | 2024 | 7133 | 0.040 |
Why?
|
Dermatologic Agents | 1 | 2004 | 314 | 0.040 |
Why?
|
Songbirds | 1 | 2019 | 23 | 0.040 |
Why?
|
Research Personnel | 1 | 2024 | 591 | 0.040 |
Why?
|
Recovery of Function | 2 | 2020 | 2994 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6353 | 0.040 |
Why?
|
Disasters | 1 | 2005 | 522 | 0.040 |
Why?
|
Synaptic Potentials | 1 | 2018 | 44 | 0.040 |
Why?
|
Cerebrovascular Circulation | 1 | 2009 | 2737 | 0.040 |
Why?
|
Principal Component Analysis | 2 | 2013 | 949 | 0.040 |
Why?
|
Stroke | 2 | 2018 | 9790 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 13025 | 0.040 |
Why?
|
Decision Trees | 1 | 2020 | 510 | 0.040 |
Why?
|
Tetraethylammonium | 1 | 1998 | 55 | 0.040 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 1998 | 57 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5455 | 0.040 |
Why?
|
Stochastic Processes | 1 | 2019 | 359 | 0.040 |
Why?
|
Intracellular Membranes | 1 | 1999 | 388 | 0.040 |
Why?
|
Afferent Pathways | 1 | 1999 | 304 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2011 | 6657 | 0.040 |
Why?
|
Hand | 2 | 2014 | 907 | 0.040 |
Why?
|
Epilepsy, Partial, Motor | 1 | 2017 | 5 | 0.040 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2019 | 170 | 0.040 |
Why?
|
Nickel | 1 | 1998 | 126 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1629 | 0.040 |
Why?
|
Probability | 2 | 2013 | 2483 | 0.030 |
Why?
|
Cohort Studies | 5 | 2022 | 41782 | 0.030 |
Why?
|
Cells, Cultured | 3 | 1998 | 19035 | 0.030 |
Why?
|
Tetrodotoxin | 1 | 1998 | 245 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2018 | 9066 | 0.030 |
Why?
|
Motor Endplate | 1 | 1996 | 20 | 0.030 |
Why?
|
Sensation | 1 | 2018 | 337 | 0.030 |
Why?
|
Mental Disorders | 1 | 2016 | 6879 | 0.030 |
Why?
|
Egtazic Acid | 1 | 1996 | 166 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 962 | 0.030 |
Why?
|
Sclerosis | 1 | 2016 | 213 | 0.030 |
Why?
|
Physical Endurance | 1 | 2018 | 370 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1015 | 0.030 |
Why?
|
Computational Biology | 2 | 2021 | 3549 | 0.030 |
Why?
|
Nerve Endings | 2 | 1993 | 105 | 0.030 |
Why?
|
Logistic Models | 2 | 2022 | 13323 | 0.030 |
Why?
|
Phenytoin | 1 | 2016 | 190 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1998 | 452 | 0.030 |
Why?
|
Carbamazepine | 1 | 2016 | 224 | 0.030 |
Why?
|
Cats | 1 | 2016 | 978 | 0.030 |
Why?
|
Cell Membrane | 2 | 2009 | 3663 | 0.030 |
Why?
|
Drosophila melanogaster | 3 | 1993 | 1725 | 0.030 |
Why?
|
Information Dissemination | 1 | 2023 | 1138 | 0.030 |
Why?
|
Chronic Disease | 2 | 2020 | 9379 | 0.030 |
Why?
|
Hemoglobins | 2 | 2013 | 1532 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1078 | 0.030 |
Why?
|
Potassium Channels | 1 | 1998 | 538 | 0.030 |
Why?
|
North America | 1 | 2018 | 1292 | 0.030 |
Why?
|
Recurrence | 2 | 2018 | 8510 | 0.030 |
Why?
|
Histamine | 1 | 2016 | 500 | 0.030 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 491 | 0.030 |
Why?
|
Evoked Potentials, Auditory | 1 | 2018 | 533 | 0.030 |
Why?
|
Markov Chains | 1 | 2018 | 977 | 0.030 |
Why?
|
Communication Aids for Disabled | 1 | 2014 | 56 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2126 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 815 | 0.030 |
Why?
|
Chelating Agents | 1 | 1996 | 385 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9425 | 0.030 |
Why?
|
Computers | 1 | 2017 | 592 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7863 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7449 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2018 | 621 | 0.030 |
Why?
|
Tape Recording | 1 | 2014 | 77 | 0.030 |
Why?
|
Neurites | 1 | 1996 | 391 | 0.030 |
Why?
|
Presynaptic Terminals | 1 | 1996 | 302 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5996 | 0.030 |
Why?
|
Valproic Acid | 1 | 2016 | 443 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 26394 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 1997 | 666 | 0.030 |
Why?
|
Infant | 2 | 2013 | 36496 | 0.030 |
Why?
|
Ear | 1 | 2014 | 172 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 74915 | 0.030 |
Why?
|
Optics and Photonics | 2 | 2009 | 307 | 0.030 |
Why?
|
Glutamic Acid | 1 | 1999 | 1192 | 0.030 |
Why?
|
Glasgow Outcome Scale | 1 | 2013 | 104 | 0.030 |
Why?
|
Signal Transduction | 1 | 1996 | 23639 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2023 | 2910 | 0.030 |
Why?
|
Monitoring, Ambulatory | 1 | 2016 | 357 | 0.030 |
Why?
|
Brain Stem | 1 | 2018 | 862 | 0.030 |
Why?
|
Long-Term Care | 1 | 2017 | 633 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2013 | 368 | 0.030 |
Why?
|
Feedback | 1 | 2016 | 794 | 0.030 |
Why?
|
Child, Preschool | 2 | 2013 | 42620 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1505 | 0.030 |
Why?
|
Animals, Newborn | 1 | 1998 | 2696 | 0.020 |
Why?
|
Postoperative Period | 1 | 2017 | 1833 | 0.020 |
Why?
|
Reflex, Pupillary | 1 | 2012 | 62 | 0.020 |
Why?
|
Coculture Techniques | 1 | 1996 | 1343 | 0.020 |
Why?
|
International Cooperation | 1 | 2018 | 1439 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2018 | 1734 | 0.020 |
Why?
|
Brain Diseases | 1 | 2020 | 1553 | 0.020 |
Why?
|
Oxygen | 2 | 2013 | 4269 | 0.020 |
Why?
|
Drinking | 1 | 2012 | 198 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12096 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2023 | 2913 | 0.020 |
Why?
|
Isoquinolines | 1 | 1992 | 354 | 0.020 |
Why?
|
Larva | 1 | 1992 | 514 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2018 | 1188 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2016 | 1140 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2730 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2950 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2012 | 796 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2016 | 1994 | 0.020 |
Why?
|
Motion | 1 | 2013 | 788 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1839 | 0.020 |
Why?
|
Suicide | 1 | 2020 | 1608 | 0.020 |
Why?
|
Nervous System | 1 | 1992 | 547 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2023 | 5371 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 1996 | 2640 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7245 | 0.020 |
Why?
|
Kinetics | 2 | 2012 | 6347 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3463 | 0.020 |
Why?
|
United States | 3 | 2024 | 73120 | 0.020 |
Why?
|
Oxyhemoglobins | 1 | 2009 | 213 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8905 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2010 | 441 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2020 | 3738 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1379 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2655 | 0.020 |
Why?
|
Neurosurgery | 1 | 2014 | 690 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 2003 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2861 | 0.020 |
Why?
|
Anisotropy | 1 | 2010 | 1296 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2015 | 12450 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3438 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2009 | 1090 | 0.020 |
Why?
|
Choice Behavior | 1 | 2011 | 846 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2021 | 4340 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9558 | 0.020 |
Why?
|
Registries | 2 | 2016 | 8372 | 0.020 |
Why?
|
Aphasia, Broca | 1 | 2005 | 52 | 0.020 |
Why?
|
Indonesia | 1 | 2005 | 129 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15879 | 0.020 |
Why?
|
Empyema, Pleural | 1 | 2005 | 62 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2019 | 11674 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 1992 | 1924 | 0.010 |
Why?
|
Head | 1 | 2010 | 927 | 0.010 |
Why?
|
Functional Laterality | 1 | 2010 | 2268 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10358 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8051 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2009 | 1882 | 0.010 |
Why?
|
Contracture | 1 | 2005 | 236 | 0.010 |
Why?
|
Risk Assessment | 2 | 2014 | 24310 | 0.010 |
Why?
|
Anesthesia | 1 | 2013 | 1596 | 0.010 |
Why?
|
Pneumothorax | 1 | 2005 | 393 | 0.010 |
Why?
|
Inpatients | 1 | 2013 | 2561 | 0.010 |
Why?
|
Phenotype | 2 | 2016 | 16712 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5887 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3407 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2014 | 2659 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10601 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8610 | 0.010 |
Why?
|
Hemodynamics | 1 | 2009 | 4202 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6856 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2010 | 2823 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2103 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10784 | 0.010 |
Why?
|
Valine | 1 | 1999 | 410 | 0.010 |
Why?
|
Dyspnea | 1 | 2005 | 1352 | 0.010 |
Why?
|
Administration, Oral | 1 | 2004 | 4040 | 0.010 |
Why?
|
Calcium Channels | 1 | 1999 | 624 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15965 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7955 | 0.010 |
Why?
|
Morphogenesis | 1 | 1993 | 747 | 0.010 |
Why?
|
Lasers | 1 | 1993 | 952 | 0.000 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2005 | 4636 | 0.000 |
Why?
|
Lung | 1 | 2005 | 10090 | 0.000 |
Why?
|
Enhancer Elements, Genetic | 1 | 1993 | 1368 | 0.000 |
Why?
|
Hot Temperature | 1 | 1993 | 1438 | 0.000 |
Why?
|
Axons | 1 | 1993 | 1678 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1993 | 11139 | 0.000 |
Why?
|
Mutation | 2 | 1993 | 30235 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1993 | 9261 | 0.000 |
Why?
|